CNE1000020H3
CNE1000020H3
MAKER BIOTECHNOLOGY
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 2.170.468.429 | 2.548.756.679 | 14.8% |
| Cost of Revenue | 890.544.630 | 1.144.092.242 | 22.2% |
| Gross Profit | 1.279.923.799 | 1.404.664.437 | 8.9% |
| 1.225.166.850 | 1.125.499.343 | 8.9% | |
| Operating Income | 54.756.949 | 279.165.094 | 80.4% |
| Pretax Income | -99.537.391 | 124.651.405 | 179.9% |
| Net Income Common Stockholders | -35.826.986 | 126.805.275 | 128.3% |
| -- | -- | -- | |
| -- | -- | -- |